SPL 0.00% 10.5¢ starpharma holdings limited

Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-54

  1. 5,071 Posts.
    lightbulb Created with Sketch. 567
    are you suggesting we or a collaboration has had proper clinical trial?

    covid and then need for viraleze has some what ease as new antivirals are hitting the market and having greater affect, the but for me is what are the new antiviral in term of side effects,
    i haven't had booster shots, and i don't trust the vac, a relative had a combo flu and covid shot and was voilently ill, much worse than covid itself.
    i would say that recent survrey about dropping the term long covid is plain stupid,
    i was happy to see, some one point out that the survey did not take in those that went to hostipal with covid, nor the aged care sector....only via txt to those that had a PCR, so the result are totallly flawed and look inspired by Gov agenda to squash any talk of covid as a problem.
    i suffered and may still be suffering covid ...as a long termer. very wierd side effects.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $43.29M
Open High Low Value Volume
10.0¢ 10.5¢ 10.0¢ $12.03K 116.6K

Buyers (Bids)

No. Vol. Price($)
1 3000 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 109616 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.